Virus-Associated T-Cell Activation Correlate of Human Immunodeficiency Regeneration and Tolerance Factor : a

[1]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[2]  K. Beaman,et al.  Increased Expression of Regeneration and Tolerance Factor in Individuals with Human Immunodeficiency Virus Infection , 1999, Clinical Diagnostic Laboratory Immunology.

[3]  R. Detels,et al.  The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. , 1999, Clinical immunology.

[4]  F. Malavasi,et al.  The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38 , 1999, Journal of leukocyte biology.

[5]  S. Gullans,et al.  Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. , 1998, Immunity.

[6]  R. Detels,et al.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[7]  D. Quaglino,et al.  Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry. , 1997, American journal of clinical pathology.

[8]  H. Kosmehl,et al.  Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta 1 in primary cultures and modulate T lymphocyte blast transformation. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[9]  R. Detels,et al.  Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes , 1997, Clinical and diagnostic laboratory immunology.

[10]  R. Ramesh,et al.  Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. , 1996, Human pathology.

[11]  L. Montagnier,et al.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. , 1996, Journal of immunology.

[12]  A. Gilman‐Sachs,et al.  TJ6: The Pregnancy‐Associated Cytokine , 1996, American journal of reproductive immunology.

[13]  T. Idziorek,et al.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons , 1995, The Journal of experimental medicine.

[14]  K. Beaman,et al.  Reciprocal Alteration in Circulating TJ6+ CD19+ and TJ6+ CD56+ Leukocytes in Early Pregnancy Predicts Success or Miscarriage , 1995, American journal of reproductive immunology.

[15]  K. Beaman,et al.  Purification and Characterization of a Pregnancy‐Associated Protein: TJ6s , 1995, American journal of reproductive immunology.

[16]  D. Vergani,et al.  Markers of immune cell activation and disease progression. Cell activation in HIV disease. , 1995, Advances in experimental medicine and biology.

[17]  M. Clerici,et al.  The Th1-Th2 hypothesis of HIV infection: new insights. , 1994, Immunology today.

[18]  J. Margolick,et al.  CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. , 1994, The Journal of infectious diseases.

[19]  T. Nichols,et al.  Expression of a membrane form of the pregnancy-associated protein TJ6 on lymphocytes. , 1994, Cellular immunology.

[20]  T. Mosmann,et al.  Synthesis of T helper 2-type cytokines at the maternal-fetal interface. , 1993, Journal of immunology.

[21]  D. Vergani,et al.  T cell activation and disease severity in HIV infection , 1993, Clinical and experimental immunology.

[22]  R. Detels,et al.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[23]  T. Mosmann,et al.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.

[24]  L. Montagnier,et al.  Apoptosis in AIDS. , 1993, Science.

[25]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[26]  D. Botstein,et al.  The VPH1 gene encodes a 95-kDa integral membrane polypeptide required for in vivo assembly and activity of the yeast vacuolar H(+)-ATPase. , 1992, The Journal of biological chemistry.

[27]  K. Beaman,et al.  T-cell suppressor factors play an integral role in preventing fetal rejection. , 1988, Journal of reproductive immunology.